← All stocks

Shuttle Pharmaceuticals Holdings, Inc.

SHPH Net selling
CIK 0001757499 #5571 in the set updated 18 Sep 2026
Bought (120 mo)
$181.76K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$548.48K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$548.48K
17 of 17 sales
Net
−$366.72K
−$366.72K against sales at will

By person

11 insiders · 23 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
HRT FINANCIAL LP entity
10% owner
$181.76K (6)
$504.83K (5)
−$323.07K
0
$0.00
−100.0%
Dritschilo Anatoly
CEO and Chairman
$13.44K (1)
−$13.44K
3,185,200
$14.27M
−0.3%
Jacobs Bette
Director
$8.93K (2)
−$8.93K
58,285
$261.12K
−12.8%
Dritschilo Peter
President and COO
$6.13K (1)
−$6.13K
6,560
$29.39K
−36.8%
Vander Hoek Michael
Chief Financial Officer
$3.60K (1)
−$3.60K
103,852
$465.26K
+1,604%
Brown Milton
Director
$2.95K (2)
−$2.95K
1,094,610
$4.90M
−0.4%
Senanayake Chris
Director
$2.61K (1)
−$2.61K
2,791
$12.50K
−36.8%
Rich Tyvin
Chief Medical Officer
$2.27K (1)
−$2.27K
2,429
$10.88K
−36.8%
Adkins William
Former Director
$1.60K (1)
−$1.60K
184,071
$824.64K
−0.5%
Richards Steven M
Director
$1.60K (1)
−$1.60K
1,707
$7.65K
−36.8%
Jung Mira
Chief Scientific Officer
$526.44 (1)
−$526.44
135,715
$608.00K
−0.7%

No percentages here. This company's share count has moved by a factor of 5.2 over the window, from 1,070,773 to 5,591,290 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 27
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 4,300,598
Sales filed before the plan box existed 9
History held since 30 Dec 2022